Transparent Coverage of Clinical Trials and Research | TrialSite News

Weekly Roundup

Podcast

Top News Stories

PGIMER Led Convalescent Plasma Study: Convalescent Plasma Doesn’t Stop COVID-19 Disease Progression or Lower Mortality Rate

PGIMER Led Convalescent Plasma Study: Convalescent Plasma Doesn’t Stop COVID-19 Disease Progression or Lower Mortality Rate

September 17, 2020

Prominent Japanese Academic Medical Center Launching Ivermectin Clinical Trial Targeting COVID-19

Prominent Japanese Academic Medical Center Launching Ivermectin Clinical Trial Targeting COVID-19

September 17, 2020

MemorialCare Long Beach Medical Center Initiates REGN-COV2 Monoclonal Antibody Study Targeting COVID-19

MemorialCare Long Beach Medical Center Initiates REGN-COV2 Monoclonal Antibody Study Targeting COVID-19

September 17, 2020

University of Arkansas Medical Sciences’ Investigator Receives $1.7m to Advance Myeloma Research

University of Arkansas Medical Sciences’ Investigator Receives $1.7m to Advance Myeloma Research

September 17, 2020

Cleveland Clinic’s Center for Emerging Pathogens Research Takes on Readiness for Future Public Health Crises

Cleveland Clinic’s Center for Emerging Pathogens Research Takes on Readiness for Future Public Health Crises

September 17, 2020

DoD & U.S. Army Fund & Manage Innovative Regenerative Study Targeting Acute Knee Injuries

DoD & U.S. Army Fund & Manage Innovative Regenerative Study Targeting Acute Knee Injuries

September 17, 2020

Digital Media

Roseanne Onyia of Clinique Research Development Limited Talks with us About Clinical Research in Nigeria | Podcast S2 E 35

Roseanne Onyia of Clinique Research Development Limited Talks with us About Clinical Research in Nigeria | Podcast S2 E 35

September 16, 2020

Clinical Trials and Research News Weekly Roundup | Ivermectin Moves Towards Mainstream

Clinical Trials and Research News Weekly Roundup | Ivermectin Moves Towards Mainstream

September 14, 2020

Bree Burks of Veeva Systems Discusses What Clinical Trials Will Look Like Post COVID-19 | Podcast S2 E 34

Bree Burks of Veeva Systems Discusses What Clinical Trials Will Look Like Post COVID-19 | Podcast S2 E 34

September 9, 2020

Clinical Trials and Research News Weekly Roundup | Zagazig University Ivermectin VS COVID-19

Clinical Trials and Research News Weekly Roundup | Zagazig University Ivermectin VS COVID-19

September 7, 2020

Watchlist Series | AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline

Watchlist Series | AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline

September 6, 2020

Dr. Jordan Dubow Addressing the Unmet need in the Narcolepsy Treatment Landscape | Podcast S2 E 33

Dr. Jordan Dubow Addressing the Unmet need in the Narcolepsy Treatment Landscape | Podcast S2 E 33

September 2, 2020

Blog

Prominent Japanese Academic Medical Center Launching Ivermectin Clinical Trial Targeting COVID-19

Prominent Japanese Academic Medical Center Launching Ivermectin Clinical Trial Targeting COVID-19

September 17, 2020

FDA Authorizes Seattle-based AVM Biotechnology to Proceed with Clinical Trials in COVID-19

FDA Authorizes Seattle-based AVM Biotechnology to Proceed with Clinical Trials in COVID-19

September 16, 2020

People’s Liberation Army Helped China Develop Ad5-nCoV COVID-19 Vaccine, While State-Owned SinoPharm’s Vaccine Moves Toward Approval

People’s Liberation Army Helped China Develop Ad5-nCoV COVID-19 Vaccine, While State-Owned SinoPharm’s Vaccine Moves Toward Approval

September 16, 2020

Russian Vaccine Redux: EpiVacCorona “Approval” Soon?

Russian Vaccine Redux: EpiVacCorona “Approval” Soon?

September 12, 2020

Ivermectin Moves Towards Mainstream

Ivermectin Moves Towards Mainstream

September 5, 2020

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

September 4, 2020

Trial Watch

Northwell Health & the Feinstein Institutes for Medical Research One Step Closer to Groundbreaking Lupus Drug

Northwell Health & the Feinstein Institutes for Medical Research One Step Closer to Groundbreaking Lupus Drug

September 17, 2020

Lilly’s LY-CoV555 Shows Promise Targeting COVID-19 With Phase 2 Interim Analysis

Lilly’s LY-CoV555 Shows Promise Targeting COVID-19 With Phase 2 Interim Analysis

September 16, 2020

Data from BioMarin’s Phase 3 Trial of Vosoritide in Children with Achondroplasia Published in The Lancet

Data from BioMarin’s Phase 3 Trial of Vosoritide in Children with Achondroplasia Published in The Lancet

September 11, 2020

Spero Therapeutics Announces Positive Results from Phase 3 ADAPT-PO Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis

Spero Therapeutics Announces Positive Results from Phase 3 ADAPT-PO Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis

September 10, 2020

Albireo Pharma Reports Positive Data from Phase 3 Trial Evaluating Odevixibat for Rare Genetic Liver Disease

Albireo Pharma Reports Positive Data from Phase 3 Trial Evaluating Odevixibat for Rare Genetic Liver Disease

September 10, 2020

Amryt Pharma’s Filsuvez Reaches Primary Endpoints in Phase 3 Trial in Patients with Epidermolysis Bullosa

Amryt Pharma’s Filsuvez Reaches Primary Endpoints in Phase 3 Trial in Patients with Epidermolysis Bullosa

September 10, 2020

Site Watch

Eli Lilly’s BLAZE-1 Selects Aventiv Research in Columbus as Ohioans Investigate Advanced Monoclonal Antibodies Targeting COVID-19

Eli Lilly’s BLAZE-1 Selects Aventiv Research in Columbus as Ohioans Investigate Advanced Monoclonal Antibodies Targeting COVID-19

September 16, 2020

Moderna COVID-19 Vaccine Study: GWU Ahead of Many Trial Sites for Minority Recruiting

Moderna COVID-19 Vaccine Study: GWU Ahead of Many Trial Sites for Minority Recruiting

September 15, 2020

Columbia University Research Returned, Reactivated and Approaching 100% Capacity

Columbia University Research Returned, Reactivated and Approaching 100% Capacity

September 9, 2020

Rio Grande Valley-based DHR Health Institute Seeks to Participate in COVID-19 Trials

Rio Grande Valley-based DHR Health Institute Seeks to Participate in COVID-19 Trials

September 7, 2020

Nation’s Largest Chain of Hospitals Under Fire by Nurses Union

Nation’s Largest Chain of Hospitals Under Fire by Nurses Union

September 6, 2020

Temple University the Latest Academic Medical Center to Plan Ivermectin Trial: Does the Drug Inhibit SARS-CoV-2 Progression?

Temple University the Latest Academic Medical Center to Plan Ivermectin Trial: Does the Drug Inhibit SARS-CoV-2 Progression?

September 5, 2020

Investor Watch

DoD & U.S. Army Fund & Manage Innovative Regenerative Study Targeting Acute Knee Injuries

DoD & U.S. Army Fund & Manage Innovative Regenerative Study Targeting Acute Knee Injuries

September 17, 2020

FDA Authorizes Seattle-based AVM Biotechnology to Proceed with Clinical Trials in COVID-19

FDA Authorizes Seattle-based AVM Biotechnology to Proceed with Clinical Trials in COVID-19

September 16, 2020

Eli Lilly’s BLAZE-1 Selects Aventiv Research in Columbus as Ohioans Investigate Advanced Monoclonal Antibodies Targeting COVID-19

Eli Lilly’s BLAZE-1 Selects Aventiv Research in Columbus as Ohioans Investigate Advanced Monoclonal Antibodies Targeting COVID-19

September 16, 2020

German Government Awards $745m to Both BioNTech and CureVac for COVID-19 Vaccine Development

German Government Awards $745m to Both BioNTech and CureVac for COVID-19 Vaccine Development

September 16, 2020

University of Maryland Spin-off Successfully Licenses Technology to Daiichi Sankyo

University of Maryland Spin-off Successfully Licenses Technology to Daiichi Sankyo

September 15, 2020

UCSF Investigates Regenerative Cellular Therapies Targeting Often Fatal COVID-19 ARDS

UCSF Investigates Regenerative Cellular Therapies Targeting Often Fatal COVID-19 ARDS

September 15, 2020

Pharma Watch

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

July 25, 2020

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models

May 22, 2020

Ansun Biopharma’s DAS181 Shows Promise in COVID-19 Patients with Respiratory Challenges

Ansun Biopharma’s DAS181 Shows Promise in COVID-19 Patients with Respiratory Challenges

May 19, 2020

‘Unprecedented Times call for Bold Moves’ as Competitive Plasma Firms Unite to Battle COVID-19

‘Unprecedented Times call for Bold Moves’ as Competitive Plasma Firms Unite to Battle COVID-19

April 7, 2020

Acceleration of First-Patient-First-Visit Study Milestone as Roche Study Investigating Tocilizumab in COVID-19 Pneumonia Patients Enrolls Patients in Spain

Acceleration of First-Patient-First-Visit Study Milestone as Roche Study Investigating Tocilizumab in COVID-19 Pneumonia Patients Enrolls Patients in Spain

April 5, 2020

Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer

Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer

March 21, 2020

Price Watch

U.S. Gov Commits $1.5b to Moderna for mRNA-1273 as BARDA & DOD Negotiators get Shrewder

U.S. Gov Commits $1.5b to Moderna for mRNA-1273 as BARDA & DOD Negotiators get Shrewder

August 17, 2020

Gilead Submitted NDA While U.S. is Being Charged 50X What India Pays for Remdesivir in Pandemic Conditions

Gilead Submitted NDA While U.S. is Being Charged 50X What India Pays for Remdesivir in Pandemic Conditions

August 11, 2020

Vaccine Price Points Emerge and Some of the Companies Subsidized by Feds Won’t Commit to At Cost Pricing

Vaccine Price Points Emerge and Some of the Companies Subsidized by Feds Won’t Commit to At Cost Pricing

August 8, 2020

Attorney Generals Seek to Force Gilead into 1980 Bayh-Dole Act Provisions to Lower Price & Open Up Supply: Are they Naïve?

Attorney Generals Seek to Force Gilead into 1980 Bayh-Dole Act Provisions to Lower Price & Open Up Supply: Are they Naïve?

August 7, 2020

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

Novartis Moves to be on the ‘Right Side’ of History, Will Other Big Pharma Follow?

July 25, 2020

India Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences over the Evidence while Demand Soars

India Approves Itolizumab & Tocilizumab for COVID-19: Controversy Commences over the Evidence while Demand Soars

July 18, 2020

Popular Posts

24/7 News Feed

Pin It on Pinterest